RFM plus liraglutide, a GLP1 receptor agonist commonly prescribed for obesity and diabetes
The No-Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Demand. Working Paper
Both drug classes affect appetite signaling and cardiovascular hemodynamics, requiring careful provider assessment before initiation
A safe weight-management plan should track more than weight, including: Waist size Blood pressure Blood sugar Sleep Energy Mobility Long-term disease risk When to Talk to a Primary Care Provider Patients should schedule a medical visit if weight gain continues despite lifestyle changes, or if weight gain comes with fatigue, increased thirst, snoring, joint pain, irregular periods, high blood pressure, high cholesterol, or rising blood sugar
These are two independent systems that can run simultaneously without interference
In clinical trials, nausea occurred in 17-22% of patients, diarrhea in 13-16%, and vomiting in 6-10%